Searched for
PIRAMAL PHARMA USFDA
Piramal Pharma shares in focus after USFDA issues form 483 for Kentucky unitPiramal Pharma's US facility inspection concluded with four observations from the FDA. The company expects a voluntary action indicated cla...- Piramal Pharma shares in focus after US FDA issues six observations for Mumbai facilityPiramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a F...
- Stocks in news: Ambuja Cement, Alivus Life, Route Mobile, Aurobindo Pharma, LTIMindtreePiramal Enterprises announced that the administrative committee of its board of directors will meet on December 20 to consider public issua...
- Stocks in news: Zomato, LIC, Tata Consumer, Piramal Pharma, BPCLAsset management company Artisan Partners on Wednesday divested a 1.2% stake in telecom infrastructure major Indus Towers for Rs 717 crore ...
- Stocks in news: Quick Heal, Infosys, Wipro, Adani Green, SBI Life, Uno Minda, EmamiAmerican venture capital firm Sequoia Capital has exited Quick Heal Technologies Ltd, by selling its entire 3.4% stake in the company throu...
- Piramal Pharma shares jump over 10%. Here's whyPiramal Pharma's shares rose 10.2% on BSE after the US FDA concluded its inspection at the company’s Sellersville manufacturing facility. T...
- Pharma businesses with strong quality compliance to emerge stronger as pandemic impact decreases: Ajay PiramalStressing that maintaining a strong focus on quality and compliance is another important area of growing significance in the pharma sector,...
- Aurobindo Pharma, Glenmark crack on USFDA observationsAurobindo Pharma plunged 19% after USFDA flagged lack of good manufacturing practices at the Telangana plant.
- Stock market update: Pharma stocks jump up to 4%; Aurobindo Pharma, Sun Pharma hog limelightThe Nifty Pharma index was trading 2.43 per cent up at 10,644 around 10:45 am.
- Market Now: Pharma pack in pain; Biocon plunges 5% on reports of USFDA observationsCadila Healthcare, Aurobindo Pharma and Piramal Enterprises plunged up to 3 per cent.
- Market Now: Sun Pharma drags Nifty Pharma index downShares of Sun Pharma plunged on reports of USFDA inspection of its Halol plant in Gujarat.
- Market Now: Lupin drags Nifty Pharma index down by 4%21 stocks that hit fresh 52-week lows on NSE in Tuesday's trade so far.
- Financial services to dominate for some time: Ajay Piramal, Piramal EnterprisesThere is no further update on IDFC- Shriram Group merger, says Piramal
- Market Now: Pharma stocks fall; Piramal, Cipla top losersNifty Pharma index was down 52 points at 9,425 around 2 pm.
- Wrong to say USFDA has been unduly harsh on Indian pharma: PiramalIf you see, some of the observations they make for some of the FDA stoppages that they have done, these are all public, says the Chairman o...
- Piramal Enterprises Q1 net up 36% at Rs 231 croreThe company had posted a net profit after tax, minority interest and share of profit of associates of Rs 169.43 crore for the corresponding...
- Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issuesWhile most pharma companies have turned risky on account of regulatory clamps, investors have switched to companies with healthy pipeline a...
- Pharma cos don’t lose sleepIndian pharma companies say they don’t expect any negative effects on their business prospects in the US.
- Nicholas Piramal to take oncology drug overseas aloneNicholas Piramal plans to take up oncology market on its own for its anti-blood cancer drug.
- Nicholas Piramal gets FDA okay for cancer drug trialsNicholas Piramal announced on Monday that it had received approval from the USFDA to start clinical trials on humans for its new cancer dru...
Load More
